ID
31601
Description
A Study to Determine the Maximum Tolerated Dose of Elesclomol Sodium Given With a Fixed Dose of Docetaxel and Prednisone in Patients With Metastatic Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00808418
Link
https://clinicaltrials.gov/show/NCT00808418
Keywords
Versions (1)
- 9/11/18 9/11/18 -
Copyright Holder
See clinicaltrials.gov
Uploaded on
September 11, 2018
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Prostate Cancer NCT00808418
Eligibility Prostate Cancer NCT00808418
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Cardiovascular Disease
Data type
boolean
Alias
- UMLS CUI [1]
- C0007222
Description
Metastatic malignant neoplasm to brain
Data type
boolean
Alias
- UMLS CUI [1]
- C0220650
Description
Therapeutic procedure Cancer Other
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0087111
- UMLS CUI [1,2]
- C1707251
Description
Condition Uncontrolled Clinical Significance
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0348080
- UMLS CUI [1,2]
- C0205318
- UMLS CUI [1,3]
- C2826293
Similar models
Eligibility Prostate Cancer NCT00808418
- StudyEvent: Eligibility
C1265611 (UMLS CUI [1,2])
C0242656 (UMLS CUI [2])
C0031843 (UMLS CUI [1,2])
C0232804 (UMLS CUI [2])
C0232741 (UMLS CUI [3])
C1516728 (UMLS CUI [1,2])
C0013230 (UMLS CUI [2,1])
C0392877 (UMLS CUI [2,2])
C0332183 (UMLS CUI [2,3])
C1707251 (UMLS CUI [1,2])
C0205318 (UMLS CUI [1,2])
C2826293 (UMLS CUI [1,3])